Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
The Food and Drug Administration on Tuesday published a list of more than 200 brand name drugs without generic alternatives on the market. While the list leaves many drugmakers susceptible to more generic competition, Valeant Pharmaceuticals is poised to be…
Congressman Chris Collins, R-N.Y., lost nearly $17 million after stock for an Australian drug company he'd heavily invested dropped by more than 90 percent on June 27, reports The Hill.
The Securities and Exchange Commission on Tuesday charged three individuals linked to Ariad Pharmaceuticals with insider trading, reports The Boston Globe.
Lawmakers are calling on the Department of Veterans Affairs to pay medical device companies up to $15 million in late payments for implants and devices used in VA hospitals, reports The Journal Gazette.
The Food and Drug Administration on Tuesday published a list of brand name drugs without generic competition and implemented a policy to accelerate generic drug approvals.
The Food and Drug Administration has approved five biosimilars since 2010 — none of which are designated as "interchangeable" to the biologic drug they mimic, reports Regulatory Focus.
Two drug companies that use or repackage Hospira products launched secondary recalls in response to the drugmaker's June 15 recall of several injectable drugs.
Hill-Rom Holdings will sell its German hospital bed business, Völker, to a CoBE Capital affiliate.
An internal technical issue put Medtronic's computer system offline for nearly a week, disrupting the devicemaker's global supply chain, reports StarTribune.
The Food and Drug Administration granted premarket approval to Thermo Fisher Scientifics' lung cancer biomarker sequencing test.